Autophagy regulation in the development and treatment of breast cancer

Acta Biochimica et Biophysica Sinica

Volumn 48, Issue 1, 2015, Pages 60-74

  Zhou, Yuting ^a   Rucker, Edmund B ^a,b   Zhou, Binhua P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

autophagy; breast cancer; mTOR

Indexed keywords

ANTINEOPLASTIC AGENT; BECLIN 1; BECN1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL; AUTOPHAGY; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HUMAN; INFLAMMATION; LYSOSOME; METABOLISM; METASTASIS; MOUSE; PHENOTYPE; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; BECLIN-1; BREAST NEOPLASMS; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; INFLAMMATION; LYSOSOMES; MICE; NEOPLASM METASTASIS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 84960434123     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv119     Document Type: Review

References (96)

1. Wang Y, Zhou BP. Epithelial-mesenchymal transition - a hallmark of breast cancer metastasis. Cancer Hallm 2013, 1: 38-49.
2. Shi J, Cao J, Zhou BP. Twist-BRD4 complex: potential drug target for basal-like breast cancer. Curr Pharm Des 2015, 21: 1256-1261.
3. Lin Y, Dong C, Zhou BP. Epigenetic regulation of EMT: the Snail story. Curr Pharm Des 2014, 20: 1698-1705.
4. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin 2008, 40: 643-650.
5. Wu Y, Zhou BP. Inflammation: a driving force speeds cancer metastasis. Cell Cycle 2009, 8: 3267-3273.
6. Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer 2015, 14: 48.
7. Fidler IJ. Metastasis: quantitative analysis of the distribution and fate of tumor emboli labeled with 125I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 1970, 45: 773-782.
8. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990, 54: 159-211.
9. Weiss L. The biomechanics of cancer cell traffic, arrest, and intravascular destruction. In: Orr FW, Buchanan MR, Weiss L eds. Microcirculation in Cancer Metastasis. Boca Raton: CRC Press, Inc., 1991, 131-144.
10. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998, 153: 865-873.
11. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004, 6: 463-477.
12. Roy S, Debnath J. Autophagy and tumorigenesis. Semin Immunopathol 2010, 32: 383-396.
13. Lee JS, Kim YJ, Kim CL, Lee GM. Differential induction of autophagy in caspase-3/7 down-regulating and Bcl-2 overexpressing recombinant CHO cells subjected to sodium butyrate treatment. J Biotechnol 2012, 161: 34-41.
14. Qi Y, Zhang M, Li H, Frank JA, Dai L, Liu H, Zhang Z, et al. Autophagy inhibition by sustained overproduction of IL6 contributes to arsenic carcinogenesis. Cancer Res 2014, 74: 3740-3752.
15. Hale AN, Ledbetter DJ, Gawriluk TR, Rucker EB 3rd. Autophagy: regulation and role in development. Autophagy 2013, 9: 951-972.
16. Simonsen A, Tooze SA. Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 2009, 186: 773-782.
17. Hasima N, Ozpolat B. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis 2014, 5: e1509.
18. Scarlatti F, Maffei R, Beau I, Ghidoni R, Codogno P. Non-canonical autophagy: an exception or an underestimated form of autophagy? Autophagy 2008, 4: 1083-1085.
19. Orvedahl A, Levine B. Eating the enemy within:autophagy in infectious diseases. Cell Death Differ 2008, 130: 57-69.
20. Thumm M, Egner R, Koch B, Schlumpberger M, Straub M, Veenhuis M, Wolf DH. Isolation of autophagocytosis mutants of Saccharomyces cerevisiae. FEBS Lett 1994, 349: 275-280.
21. Lippai M, Low P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int 2014, 2014: 832704.
22. Shang L, Chen S, Du F, Li S, Zhao L, Wang X. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci USA 2011, 108: 4788-4793.
23. Kim J, Kundu M, Viollet B, Guan KL.AMPK andmTORregulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13: 132-141.
24. Hara T, Takamura A, Kishi C, Iemura SI, Natsume T, Guan JL, Mizushima N. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol 2008, 181: 497-510.
25. Chen Y, Wei H, Liu F, Guan JL. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J Biol Chem 2014, 289: 1164-1173.
26. Romanov J, Walczak M, Ibiricu I, Schuchner S, Ogris E, Kraft C, Martens S. Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. EMBO J 2012, 31: 4304-4317.
27. Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, Inagaki F, et al. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 2007, 282: 37298-37302.
28. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282: 24131-24145.
29. Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 2012, 19: 87-95.
30. Shen HM, Codogno P. Autophagic cell death: Loch Ness monster or endangered species? Autophagy 2011, 7: 457-465.
31. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basallike breast cancer. Cancer Cell 2013, 23: 316-331.
32. Kongara S, Kravchuk O, Teplova I, Lozy F, Schulte J, Moore D, Barnard N, et al. Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors. Mol Cancer Res 2010, 8: 873-884.
33. Debnath J. The multifaceted roles of autophagy in tumorsimplications for breast cancer. J Mammary Gland Biol Neoplasia 2011, 16: 173-187.
34. Bailey KM, Wojtkowiak JW, Hashim AI, Gillies RJ. Targeting the metabolic microenvironment of tumors. Adv Pharmacol 2012, 65: 63-107.
35. Chabner BA, Roberts TG Jr. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 2005, 5: 65-72.
36. Janku F, McConkey DJ, Hong DS, Kurzrock R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 2011, 8: 528-539.
37. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61: 69-90.
38. Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan J, Wang L. The significance of expression of autophagy-related gene Becn1, Bcl-2, and Bax in breast cancer tissues. Tumour Biol 2011, 32: 1163-1171.
39. Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007, 7: 834-846.
40. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol 2010, 7: 683-692.
41. Jain K, Paranandi KS, Sridharan S, Basu A. Autophagy in breast cancer and its implications for therapy. Am J Cancer Res 2013, 3: 251-265.
42. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999, 59: 59-65.
43. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J, et al. Impairment of starvation-induced and constitutive autophagy in Atg7- deficient mice. J Cell Biol 2005, 169: 425-434.
44. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402: 672-676.
45. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003, 112: 1809-1820.
46. O'Donovan PJ, Livingston DM. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair. Carcinogenesis 2010, 31: 961-967.
47. Cheng Y, Ren X, Hait WN, Yang JM. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev 2013, 65: 1162-1197.
48. Zhang L, Wang HD, Zhu JH, Xu JG, Ding K. Mollugin induces tumor cell apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K and ERK signaling pathways. Biochem Biophys Res Commun 2014, 450: 247-254.
49. Fan J, Dong X, Zhang W, Zeng X, Li Y, Sun Y, Wang S, et al. Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells. Appl Microbiol Biotechnol 2014, 98: 9763-9775.
50. Wang M, Tan W, Zhou J, Leow J, Go M, Lee HS, Casey PJ. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biol Chem 2008, 283: 18678-18684.
51. Campbell GR, Bruckman RS, Chu YL, Spector SA. Autophagy induction by histone deacetylase inhibitors inhibits HIV Type 1. J Biol Chem 2014, 290: 5028-5040.
52. Marrazzo A, Fiorito J, Zappalà L, Prezzavento O, Ronsisvalle S, Pasquinucci L, Scoto GM, et al. Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. Eur J Med Chem 2010, 46: 433-438.
53. Xu ZX, Liang J, Haridas V, Gaikwad A, Connolly FP, Mills GB, Gutterman JU. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase. Cell Death Differ 2007, 14: 1948-1957.
54. Lin J, Zheng Z, Li Y, Yu W, Zhong W, Tian S, Zhao F, et al. A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy 2009, 5: 314-320.
55. Jo YK, Park SJ, Shin JH, Kim Y, Hwang JJ, Cho DH, Kim JC. ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells. Biochem Biophys Res Commun 2011, 404: 1039-1043.
56. Hwang MS, Baek WK. Glucosamine induces autophagic cell death through the stimulation of ER stress in human glioma cancer cells. Biochem Biophys Res Commun 2010, 399: 111-116.
57. Jeong HS, Choi HY, Lee ER, Kim JH, Jeon K, Lee HJ, Cho SG. Involvement of caspase-9 in autophagy-mediated cell survival pathway. Biochim Biophys Acta 2011, 1813: 80-90.
58. Petrilli AM, Fuse MA, Donnan MS, Bott M, Sparrow NA, Tondera D, Huffziger J, et al. A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2. Ame J Transl Res 2014, 6: 471-U274.
59. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, Gorski SM. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 2008, 112: 389-403.
60. Schoenlein PV, Periyasamy-Thandavan S, Samaddar JS, Jackson WH, Barrett JT. Autophagy facilitates the progression of ERalpha-positive breast cancer cells to antiestrogen resistance. Autophagy 2009, 5: 400-403.
61. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D. A role for macroautophagy in protection against 4-hydroxytamoxifeninduced cell death and the development of antiestrogen resistance. Mol Cancer Ther 2008, 7: 2977-2987.
62. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, Nabi IR, et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009, 4: e7124.
63. Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res 2012, 4: 357-365.
64. Benbrook DM, Long A. Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. Exp Oncol 2012, 34: 286-297.
65. Wolff AC, Lazar AA, Bondarenko I, Garin AM, Brincat S, Chow L, Sun Y, et al. Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. J Clin Oncol 2013, 31: 195-202.
66. Vicier C, Dieci MV, Arnedos M, Delaloge S, Viens P, Andre F. Clinical development of mTOR inhibitors in breast cancer. Breast Cancer Res 2014, 16: 203.
67. Lu J, Sun D, Gao S, Gao Y, Ye J, Liu P. Cyclovirobuxine D induces autophagy-associated cell death via the Akt/mTOR pathway in MCF-7 human breast cancer cells. J Pharmacol Sci 2014, 125: 74-82.
68. Al Dhaheri Y, Attoub S, Ramadan G, Arafat K, Bajbouj K, Karuvantevida N, AbuQamar S, et al. Iratni, Carnosol induces ROSmediated beclin1-independent autophagy and apoptosis in triple negative breast cancer. PLoS One 2014, 9: e109630.
69. You J, He Z, Chen L, Deng G, Liu W, Qin L, Qiu F, et al. CH05-10, a novel indinavir analog, is a broad-spectrum antitumor agent that induces cell cyclearrest, apoptosis, endoplasmic reticulum stress andautophagy. Cancer Sci 2010, 101: 2644-2651.
70. Wang T, Goodall ML, Gonzales P, Sepulveda M, Martin KR, Gately S, MacKeigan JP. Synthesis of improved lysomotropic autophagy inhibitors. J Med Chem 2015, 58: 3025-3035.
71. Torrente E, Parodi C, Ercolani L, De Mei C, Ferrari A, Scarpelli R, Grimaldi B. Synthesis and in vitro anticancer activity of the first class of dual inhibitors of REV-ERBb and autophagy. J Med Chem 2015, 58: 5900-5915.
72. Gies E. Niclosamide prevents the formation of large ubiquitin-containing aggregates caused by proteasome inhibition. PLoS One 2010, 5: e14410.
73. Maycotte P, Thorburn A. Targeting autophagy in breast cancer. World J Clin Oncol 2014, 5: 224-240.
74. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010, 69: 20-28.
75. Alayev A, Berger SM, Kramer MY, Schwartz NS, Holz MK. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. J Cell Biochem 2015, 116: 450-457.
76. Negri T, Tarantino E, Orsenigo M, Reid JF, Gariboldi M, Zambetti M, Pierotti MA, et al. Chromosome band 17q21 in breast cancer: significant association between beclin-1 loss and HER2/NEU amplification. Genes Chromosomes Cancer 2010, 49: 901-909.
77. Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y, Kondo S, et al. Ozpolat, Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008, 4: 669-679.
78. Zhang X, Yang Y, Liang X, Zeng X, Liu Z, Tao W, Xiao X, et al. Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 2014, 4: 1085-1095.
79. Hanahan D, Wagner EF, Palmiter RD. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. Genes Dev 2007, 21: 2258-2270.
80. Jaenisch R, Mintz B. Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc Natl Acad Sci USA 1974, 71: 1250-1254.
81. Hale A, Ledbetter D, Gawriluk T, Rucker EB III. Altering autophagy: mouse models of human disease. In: Bailly Y ed. Autophagy-A Double-Edged Sword-Cell Survival or Death? InTeOp P, 2013, 121-138.
82. Wei HJ, Wei S, Gan BY, Peng X, Zou WP, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011, 25: 1510-1527.
83. Cicchini M, Chakrabarti R, Kongara S, Price S, Nahar R, Lozy F, Zhong H, et al. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven byWNT1 activation and following parity. Autophagy 2014, 10: 2036-2052.
84. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y, Liang C, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 2007, 9: 1142-1151.
85. Hong Y, Zhou Y, Wang Y, Xiao S, Liao DJ, Zhao Q. PPARgamma mediates the effects of WIN55, 212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells. Mol Biol Rep 2013, 40: 6287-6293.
86. Wang Y, Zhou YT, Zhao Q. The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26: 344-347.
87. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E, et al. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 2007, 26: 2527-2539.
88. Feng W, Huang S, Wu H, Zhang M. Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of Beclin-1. J Mol Biol 2007, 372: 223-235.
89. Ku B, Woo JS, Liang C, Lee KH, Hong HS, E X, Kim KS, et al. Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68. PLoS Pathog 2008, 4: e25.
90. Terada M, Nobori K, Munehisa Y, Kakizaki M, Ohba T, Takahashi Y, Koyama T, et al. Double transgenic mice crossed GFP-LC3 transgenic mice with alphaMyHCmCherry-LC3 transgenic mice are a new and useful tool to examine the role of autophagy in the heart. Circ J 2010, 74: 203-206.
91. Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 2011, 193: 275-284.
92. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin-1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003, 100: 15077-15082.
93. Jiang P, Mizushima N. Autophagy and human diseases. Cell Res 2014, 24: 69-79.
94. Zarzynska JM. The importance of autophagy regulation in breast cancer development and treatment. Biomed Res Int 2014, 2014: 710345.
95. Arsov I, Adebayo A, Kucerova-Levisohn M, Haye J, MacNeil M, Papavasiliou FN, Yue Z, et al. A role for autophagic protein beclin 1 early in lymphocyte development. J Immunol 2011, 186: 2201-2209.
96. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988, 54: 105-115.